| Accession Number | 0002010019-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | May 6, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | May 1, 2026 | Sale | 405 | $206.16 | $83,494.80 | 145,295 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | May 1, 2026 | Sale | 560 | $200.95 | $112,533.29 | 144,735 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | May 1, 2026 | Sale | 520 | $201.60 | $104,832.21 | 144,215 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | May 1, 2026 | Sale | 505 | $203.32 | $102,674.33 | 143,710 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | May 1, 2026 | Sale | 865 | $204.47 | $176,862.83 | 142,845 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | May 1, 2026 | Sale | 400 | $205.31 | $82,123.00 | 142,445 | Direct | โ | View Details | |
PRESIDENT, CLINICALDIAGNOSTICS | Common Stock | โ | May 1, 2026 | Sale | 150 | $206.93 | $31,039.50 | 142,295 | Direct | โ | View Details |